The role of chemoattractant receptors in central nervous system diseases

趋化受体在中枢神经系统疾病中的作用

基本信息

  • 批准号:
    7650302
  • 负责人:
  • 金额:
    $ 5.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Inflammation plays an important role in central nervous system (CNS) infection and the progression of neurodegenerative diseases such as HIV-associated dementia and Alzheimer's disease (AD). The presence of an abundant number of activated microglial cells in amyloid plaques and the elevated levels of pro-inflammatory molecules in CNS support the contribution of chemoattractant receptors and inflammation to the pathogenesis of AD. It is clear that a balance between pro- and anti-inflammatory signals in the CNS is important in the initiation and progression of AD. Interleukin 4 (IL-4) and other anti-inflammatory cytokines, such as IL-13, differentially regulate microglial responses to amyloid beta 1-42 (A242), the pathogenic peptide in AD; which indicates that IL-4 and IL-13 have the potential to regulate inflammatory processes associated with this neurodegenerative disease. All these evidences prompted us to hypothesize that IL-4, by regulating the activation of microglial cells and its expression of key chemoattractant receptors that participate in neuroinflammation, may provide protection against the deleterious effects of proinflammatory stimuli in the CNS. The specific aims of this study are: 1) To evaluate the effects of IL-4 on the survival and activation of microglial cells. 2) To examine the regulation of chemoattractant receptors in macrophages and microglia by interleukin 4. 3) To further dissect the signaling pathways involved in the effects of IL-4 on microglial cells. Significance: The completion of these goals will provide insights into the role of IL-4 in the regulation of neuroinflammation and the definition of potential molecular targets for the development of therapeutic approaches to treat AD and neurodegenerative diseases. PUBLIC HEALTH RELEVANCE: The presence of an abundant number of activated microglial cells in the brain support the contribution of chemoattractant receptors and inflammation to the pathogenesis of Alzheimer's disease (AD). Interleukin 4 (IL- 4) may provide protection against the deleterious effects of pro-inflammatory stimuli in the central nervous system. The completion of the goals proposed in this project will provide insights into the role of IL-4 in the regulation of neuroinflammation and the definition of potential molecular targets for the development of therapeutic approaches to treat AD and other neurodegenerative diseases.
描述(由申请人提供):炎症在中枢神经系统(CNS)感染和神经退行性疾病(如hiv相关痴呆和阿尔茨海默病(AD))的进展中起重要作用。淀粉样斑块中大量活化的小胶质细胞的存在以及中枢神经系统中促炎分子水平的升高支持了趋化受体和炎症在AD发病机制中的作用。很明显,中枢神经系统中促炎和抗炎信号之间的平衡在AD的发生和发展中很重要。白细胞介素4 (IL-4)和其他抗炎细胞因子,如IL-13,差异调节小胶质细胞对淀粉样蛋白β 1-42 (A242)的反应,A242是阿尔茨海默病的致病肽;这表明IL-4和IL-13有可能调节与这种神经退行性疾病相关的炎症过程。所有这些证据提示我们假设IL-4可能通过调节参与神经炎症的小胶质细胞的激活及其关键化学引诱剂受体的表达,为中枢神经系统抗促炎刺激的有害作用提供保护。本研究的具体目的是:1)评价IL-4对小胶质细胞存活和活化的影响。2)研究白细胞介素4对巨噬细胞和小胶质细胞中趋化受体的调控作用。3)进一步剖析IL-4对小胶质细胞影响的信号通路。意义:这些目标的完成将有助于深入了解IL-4在神经炎症调节中的作用,并为开发治疗AD和神经退行性疾病的治疗方法提供潜在的分子靶点。公共卫生相关性:大脑中大量激活的小胶质细胞的存在支持了趋化受体和炎症对阿尔茨海默病(AD)发病机制的贡献。白细胞介素4 (IL- 4)可能对中枢神经系统的促炎刺激的有害作用提供保护。本项目提出的目标的完成将为IL-4在神经炎症调节中的作用提供见解,并为开发治疗AD和其他神经退行性疾病的治疗方法提供潜在分子靶点的定义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PABLO IRIBARREN其他文献

PABLO IRIBARREN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PABLO IRIBARREN', 18)}}的其他基金

The role of chemoattractant receptors in central nervous system diseases
趋化受体在中枢神经系统疾病中的作用
  • 批准号:
    8274293
  • 财政年份:
    2008
  • 资助金额:
    $ 5.03万
  • 项目类别:
The role of chemoattractant receptors in central nervous system diseases
趋化受体在中枢神经系统疾病中的作用
  • 批准号:
    7499431
  • 财政年份:
    2008
  • 资助金额:
    $ 5.03万
  • 项目类别:
The role of chemoattractant receptors in central nervous system diseases
趋化受体在中枢神经系统疾病中的作用
  • 批准号:
    8094284
  • 财政年份:
    2008
  • 资助金额:
    $ 5.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了